why is moderna stock down so much
Moderna reported revenue of 5 billion and earnings of 770 per share. After hitting a high of 9485 on July 17 Modernas stock has now fallen by about 25.
Buy Moderna Stock It S More Than A One Hit Wonder Barron S
The biotech reported its second-quarter results before the market opened.

. 2 2Why Moderna Stock Is on Fire Today The Motley Fool. 13 Wall Street analysts have issued 1 year price targets for Modernas stock. Modernas stock has pulled back.
MRNA fell 9 on Tuesday as the biotech raced to determine if its coronavirus vaccine is effective against a highly contagious. There is a broad sell-off in the market and SP 500 is down. Although it wasnt down by as much as the SP 500 index Moderna was still off by almost 2 in late afternoon trading.
BNTX and Moderna NASDAQ. However the market is worried that the. Positive news from a top rival was a key reason why.
Currently analysts expect that Moderna will report earnings of 2832 per share in 2022 so the stock is trading at 5 forward PE. On average they expect the. Shares of Moderna MRNA -466 are slumping today down 39 as of 1129 am.
The more likely factors driving it lower were an overall stock market decline and the news that Sanofi. ET on Thursday after having been off by as much as 59 earlier. Shares of BioNTech NASDAQ.
While Moderna stock may have moved 2020 has created many pricing discontinuities which can offer attractive trading opportunities. Moderna Biontech Lose 60 Billion In Value In Two Day Drop Bloomberg Is Moderna Stock Too. The stock is down by about -76 this year.
Shares of Moderna MRNA -769 fell 9 on Wednesday after Scandinavian health officials said they would take action to limit the use of the drugmakers COVID-19 vaccine in children and young adults. Shares of Moderna are down by 7 today as higher Treasury yields put significant pressure on high-growth stocks. The low in the last 52 weeks of Moderna stock was 11506.
What was the 52-week low for Moderna stock. The study found that the drug reduced. Their MRNA share price forecasts range from 10100 to 30400.
Shares of Moderna MRNA 828 were falling in January as the biotech stock was affected by the broad sell-off in growth stocks and as investors seemed to fear that the. Shares of Moderna found themselves under strong pressure after Merck announced the resuls of the study for its antiviral drug molnupiravir. While Moderna stock currently trades at a low price-to-earnings ratio thats because of bumper profits from its COVID vaccine and investors expect those to fade away.
According to the current price Moderna is 11561 away from the. PFE stock was down 35. Shares of Moderna NASDAQ.
However that wasnt the reason why Modernas stock price slid. Shares of Moderna gained strong downside momentum after the company released its third-quarter report. News that a pair of large and important customers have declined to exercise options for more Spikevax doses sent Moderna shares down by slightly more than 6 on the day.
However Pfizer and BioNTech actually had good news. MRNA were sinking 76 and 82 respectively.
Moderna Stock Is Trying To End Its Five Day Losing Streak Barron S
Moderna S Covid Vaccine Success Made The Stock A Big Pandemic Winner Will The Run Continue Fortune
Restoring Shareholder Confidence When Your Stock Is Down
Merck Covid 19 Pill Success Slams Moderna Shares Shakes Up Healthcare Sector Reuters
Dow Closes Down More Than 900 Points As New Covid Variant Sparks Market Sell Off
Merck Cashes In On Moderna Covid 19 Vaccine Enthusiasm With Sale Of Equity Stake Fierce Pharma
Why Moderna Stock Plunged Today The Motley Fool
Biopharma S Stock Market Winners And Losers So Far This Year Evaluate
Moderna Stock Drops After Bmo Analyst Recommends Taking Profit Marketwatch
Moderna Stock Extends Rally After Price Target Gets A 77 Boost At Morgan Stanley Marketwatch
Global Markets Swoon As Worries Mount Over Superpowers Plans The New York Times
Moderna Slashes Covid Vaccine Outlook As Focus Shifts To Global Markets S P Global Market Intelligence
Oil And Stock Markets Hit By Omicron Worries And Fears Of Faster Fed Tapering As It Happened Business The Guardian
Breaking Down Moderna S Covid 19 Patent Pledge Why Did They Do It
Novavax S Covid Vaccine Is Real Competition For Pfizer And Moderna Barron S
With War In Europe Investors Flee Stocks Seek Refuge In Gold Bonds
Rare Heart Related Side Effects Higher With Moderna Covid Vaccine Cidrap